# Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gemcitabine-plus-cisplatin-versus-fluorouracil-plus-cisplatin-in-recurrent-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Li Zhang,Yan Huang,Shaodong Hong,Yunpeng Yang,Gengsheng Yu,Jun Jia,Peijian Peng,Xuan Wu,Qing Lin,Xuping Xi,Jiewen Peng,Mingjun Xu,Dongping Chen,Xiaojun Lu,Rensheng Wang,Xiaolong Cao,Xiaozhong Chen,Zhixiong Lin,Jianping Xiong,Qin Lin,Conghua Xie,Zhihua Li,Jianji Pan,Jingao Li,Shixiu Wu,Yingni Lian,Quanlie Yang,Chong Zhao |
| Citations | 531 |
| DOI | 10.1016/s0140-6736(16)31388-5 |
| Fields | Dentistry,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2512237822 |
| PMID | 27567279 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Yunpeng Yang](https://scholariq.org/researchers/yunpeng-yang/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

## Paper topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Oral health in cancer treatment](https://scholariq.org/topics/oral-health-in-cancer-treatment/)
- [Oral Health Pathology and Treatment](https://scholariq.org/topics/oral-health-pathology-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.